Inventor
WU XIAOYUN
US36 patents
⚠️ This page may combine multiple inventors who share the name “WU XIAOYUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UAB RESEARCH FOUNDATION
5 patentsUS6555342B1Apr 29, 2003
Fusion protein delivery system and uses thereof
UAB RESEARCH FOUNDATION13 citations82
US6797462B1Sep 28, 2004
Cell-based assay for immunodeficiency virus infectivity and sensitivity
UAB RESEARCH FOUNDATION7 citations71
US7534603B2May 19, 2009
Fusion protein delivery system and uses thereof
UAB RESEARCH FOUNDATION2 citations60
US6362000B1Mar 26, 2002
Fusion protein delivery system and uses thereof
UAB RESEARCH FOUNDATION4 citations58
US7259014B2Aug 21, 2007
Fusion protein delivery system and uses thereof
UAB RESEARCH FOUNDATION0 citations50
BAYER AG
4 patentsUS11773070B2Oct 3, 2023
Dihydrooxadiazinones
BAYER AG2 citations72
US11427553B2Aug 30, 2022
Dihydrooxadiazinones
BAYER AG4 citations72
US12258323B2Mar 25, 2025
Dihydrooxadiazinones
BAYER AG1 citations63
US12427153B2Sep 30, 2025
1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases
BAYER AG0 citations51
MONSANTO TECHNOLOGY LLC
4 patentsUS7518035B2Apr 14, 2009
Promoter molecules for use in plants
MONSANTO TECHNOLOGY LLC2 citations59
US11268103B2Mar 8, 2022
Transgenic plants with enhanced traits
MONSANTO TECHNOLOGY LLC0 citations56
US11168333B2Nov 9, 2021
Transgenic plants with enhanced traits
MONSANTO TECHNOLOGY LLC0 citations56
US10323253B2Jun 18, 2019
Transgenic plants with enhanced traits
MONSANTO TECHNOLOGY LLC0 citations46
BROAD INST INC
3 patentsUS11142522B2Oct 12, 2021
Compounds, compositions and methods for cancer treatment
BROAD INST INC4 citations72
US12325880B2Jun 10, 2025
Identification of PDE3 modulator responsive cancers
BROAD INST INC1 citations63
US11207320B2Dec 28, 2021
Compositions and methods for cancer expressing PDE3A or SLFN12
BROAD INST INC0 citations59